Choksi Laboratories [CHOKSILA] vs Krsnaa Diagnostics [KRSNAA] Detailed Stock Comparison
Choksi Laboratories
BSE
Loading...
Krsnaa Diagnostics
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Choksi Laboratories wins in 3 metrics, Krsnaa Diagnostics wins in 15 metrics, with 0 ties. Krsnaa Diagnostics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Choksi Laboratories | Krsnaa Diagnostics | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 101.93 | 33.93 | Krsnaa Diagnostics |
| Price-to-Book Ratio | 6.63 | 3.02 | Krsnaa Diagnostics |
| Debt-to-Equity Ratio | 123.52 | 23.06 | Krsnaa Diagnostics |
| PEG Ratio | N/A | 2.35 | N/A |
| EV/EBITDA | 16.17 | 13.74 | Krsnaa Diagnostics |
| Profit Margin (TTM) | 3.52% | 10.84% | Krsnaa Diagnostics |
| Operating Margin (TTM) | 10.90% | 15.42% | Krsnaa Diagnostics |
| EBITDA Margin (TTM) | 10.90% | 15.42% | Krsnaa Diagnostics |
| Return on Equity | 6.45% | 8.79% | Krsnaa Diagnostics |
| Return on Assets (TTM) | 2.33% | 6.06% | Krsnaa Diagnostics |
| Free Cash Flow (TTM) | $40.91M | $-393.00M | Choksi Laboratories |
| Dividend Yield | N/A | 0.36% | N/A |
| 1-Year Return | 191.98% | 11.80% | Choksi Laboratories |
| Price-to-Sales Ratio (TTM) | 3.69 | 3.62 | Krsnaa Diagnostics |
| Enterprise Value | $1.86B | $28.04B | Krsnaa Diagnostics |
| EV/Revenue Ratio | 4.39 | 3.79 | Krsnaa Diagnostics |
| Gross Profit Margin (TTM) | 85.53% | 67.46% | Choksi Laboratories |
| Revenue per Share (TTM) | $61 | $229 | Krsnaa Diagnostics |
| Earnings per Share (Diluted) | $2.20 | $24.34 | Krsnaa Diagnostics |
| Beta (Stock Volatility) | 0.16 | -0.15 | Krsnaa Diagnostics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Choksi Laboratories vs Krsnaa Diagnostics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Choksi Laboratories | -0.34% | -1.92% | 15.70% | 98.51% | 73.94% | 144.17% |
| Krsnaa Diagnostics | -0.04% | -2.03% | -5.30% | 25.27% | 10.14% | -11.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Choksi Laboratories | 191.98% | 677.21% | 1,917.89% | 1,529.26% | 937.50% | 199.25% |
| Krsnaa Diagnostics | 11.80% | 69.40% | -12.70% | -12.70% | -12.70% | -12.70% |
Performance & Financial Health Analysis: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.56B | ₹26.80B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 14,560 | 73,619 |
| 90 Day Avg. Volume | 10,119 | 113,966 |
| Last Close | ₹219.95 | ₹809.15 |
| 52 Week Range | ₹56.16 - ₹236.70 | ₹625.75 - ₹1,044.00 |
| % from 52W High | -7.08% | -22.50% |
| All-Time High | ₹236.70 (Aug 20, 2025) | ₹1,099.70 (Aug 16, 2021) |
| % from All-Time High | -7.08% | -26.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.13% |
| Quarterly Earnings Growth | -0.09% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.11% |
| Operating Margin (TTM) | 0.11% | 0.15% |
| Return on Equity (TTM) | 0.06% | 0.09% |
| Debt to Equity (MRQ) | 123.52 | 23.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹33.82 | ₹273.22 |
| Cash per Share (MRQ) | ₹0.88 | ₹21.18 |
| Operating Cash Flow (TTM) | ₹51.38M | ₹2.45M |
| Levered Free Cash Flow (TTM) | ₹15.23M | ₹776.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.36% |
| Last 12-Month Dividend | N/A | ₹2.50 |
Valuation & Enterprise Metrics Analysis: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 101.93 | 33.93 |
| Forward P/E | N/A | 20.48 |
| PEG Ratio | N/A | 2.35 |
| Price to Sales (TTM) | 3.69 | 3.62 |
| Price to Book (MRQ) | 6.63 | 3.02 |
| Market Capitalization | ||
| Market Capitalization | ₹1.56B | ₹26.80B |
| Enterprise Value | ₹1.86B | ₹28.04B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.39 | 3.79 |
| Enterprise to EBITDA | 16.17 | 13.74 |
| Risk & Other Metrics | ||
| Beta | 0.16 | -0.15 |
| Book Value per Share (MRQ) | ₹33.82 | ₹273.22 |
Financial Statements Comparison: Choksi Laboratories vs Krsnaa Diagnostics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Revenue/Sales | ₹114.00M | ₹1.86B |
| Cost of Goods Sold | ₹16.49M | ₹589.52M |
| Gross Profit | ₹97.50M | ₹1.27B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹18.64M | ₹310.28M |
| EBITDA | ₹35.45M | ₹573.71M |
| Pre-Tax Income | ₹12.59M | ₹286.03M |
| Income Tax | ₹3.38M | ₹79.27M |
| Net Income (Profit) | ₹9.21M | ₹206.76M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Cash & Equivalents | ₹6.12M | ₹38.45M |
| Total Current Assets | ₹163.21M | ₹4.14B |
| Total Current Liabilities | ₹238.75M | ₹3.05B |
| Long-Term Debt | ₹159.63M | ₹471.56M |
| Total Shareholders Equity | ₹236.05M | ₹8.83B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹471.35M | ₹6.67B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 14,560 | 73,619 |
| Average Daily Volume (90 Day) | 10,119 | 113,966 |
| Shares Outstanding | 6.97M | 32.29M |
| Float Shares | 3.37M | 17.39M |
| % Held by Insiders | 0.56% | 0.44% |
| % Held by Institutions | 0.00% | 0.15% |
Dividend Analysis & Yield Comparison: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹2.50 |
| Last 12-Month Dividend Yield | N/A | 0.36% |
| 3-Year Avg Annual Dividend | N/A | ₹2.58 |
| 3-Year Avg Dividend Yield | N/A | 0.40% |
| 3-Year Total Dividends | N/A | ₹7.75 |
| Ex-Dividend Date | N/A | Sep 13, 2024 |